Albemarle (ALB) Projected to Post Earnings on Wednesday

Albemarle (NYSE:ALBGet Free Report) will likely be releasing its Q4 2025 results after the market closes on Wednesday, February 11th. Analysts expect Albemarle to post earnings of ($0.62) per share and revenue of $1.3410 billion for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 12, 2026 at 8:00 AM ET.

Albemarle Stock Up 1.3%

Shares of Albemarle stock opened at $165.54 on Tuesday. The firm has a market cap of $19.48 billion, a PE ratio of -104.11, a P/E/G ratio of 2.92 and a beta of 1.44. The business’s 50 day simple moving average is $154.77 and its 200 day simple moving average is $113.06. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.51 and a current ratio of 2.27. Albemarle has a 52-week low of $49.43 and a 52-week high of $195.68.

Hedge Funds Weigh In On Albemarle

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Parallel Advisors LLC raised its stake in Albemarle by 5.7% in the third quarter. Parallel Advisors LLC now owns 2,408 shares of the specialty chemicals company’s stock valued at $195,000 after buying an additional 129 shares during the period. Brown Brothers Harriman & Co. increased its holdings in shares of Albemarle by 0.9% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 20,700 shares of the specialty chemicals company’s stock worth $1,678,000 after acquiring an additional 189 shares during the last quarter. MML Investors Services LLC raised its stake in Albemarle by 1.3% in the 2nd quarter. MML Investors Services LLC now owns 16,991 shares of the specialty chemicals company’s stock valued at $1,065,000 after acquiring an additional 217 shares during the period. Public Employees Retirement System of Ohio lifted its holdings in Albemarle by 0.6% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 36,710 shares of the specialty chemicals company’s stock valued at $2,976,000 after purchasing an additional 228 shares during the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA boosted its position in Albemarle by 14.3% during the third quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 2,000 shares of the specialty chemicals company’s stock worth $162,000 after purchasing an additional 250 shares during the period. Institutional investors own 92.87% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Mizuho lifted their price objective on shares of Albemarle from $132.00 to $156.00 and gave the company a “neutral” rating in a report on Monday, January 12th. JPMorgan Chase & Co. lifted their price target on shares of Albemarle from $80.00 to $195.00 and gave the company a “neutral” rating in a research note on Wednesday, January 28th. Scotiabank upgraded shares of Albemarle from a “sector perform” rating to a “sector outperform” rating and increased their price objective for the stock from $85.00 to $200.00 in a research note on Monday, January 12th. Rothschild & Co Redburn raised their price objective on Albemarle from $135.00 to $158.00 and gave the company a “buy” rating in a report on Thursday, December 4th. Finally, Oppenheimer upped their target price on Albemarle from $109.00 to $207.00 and gave the stock an “outperform” rating in a report on Wednesday, January 21st. Three investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Albemarle presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.16.

View Our Latest Report on ALB

About Albemarle

(Get Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.

Read More

Earnings History for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.